|
1
|
Genome-wide association study identifies three loci associated with melanoma risk.
|
Nat Genet
|
2009
|
3.89
|
|
2
|
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
|
Nature
|
2011
|
2.96
|
|
3
|
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
|
J Natl Cancer Inst
|
2002
|
2.70
|
|
4
|
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
|
Cancer Res
|
2006
|
2.40
|
|
5
|
Genome-wide association study identifies three new melanoma susceptibility loci.
|
Nat Genet
|
2011
|
2.29
|
|
6
|
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
|
J Med Genet
|
2006
|
2.17
|
|
7
|
Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.
|
Mol Cell Biol
|
2002
|
1.36
|
|
8
|
Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.20
|
|
9
|
A variant in FTO shows association with melanoma risk not due to BMI.
|
Nat Genet
|
2013
|
1.17
|
|
10
|
Patterns of expression of DNA repair genes and relapse from melanoma.
|
Clin Cancer Res
|
2010
|
1.09
|
|
11
|
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
|
J Med Genet
|
2013
|
1.04
|
|
12
|
A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation.
|
Genes Chromosomes Cancer
|
2005
|
1.01
|
|
13
|
The determinants of serum vitamin D levels in participants in a melanoma case-control study living in a temperate climate.
|
Cancer Causes Control
|
2011
|
1.00
|
|
14
|
Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma.
|
Genes Chromosomes Cancer
|
2010
|
1.00
|
|
15
|
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study.
|
Pigment Cell Melanoma Res
|
2012
|
0.98
|
|
16
|
Management of familial melanoma.
|
Lancet Oncol
|
2007
|
0.96
|
|
17
|
CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.
|
Melanoma Res
|
2007
|
0.92
|
|
18
|
The genetics of melanoma.
|
Br J Hosp Med (Lond)
|
2006
|
0.87
|
|
19
|
Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK.
|
J Med Genet
|
2011
|
0.87
|
|
20
|
A flexible multiplex bead-based assay for detecting germline CDKN2A and CDK4 variants in melanoma-prone kindreds.
|
J Invest Dermatol
|
2010
|
0.87
|
|
21
|
Prevalence of 9p21 deletions in UK melanoma families.
|
Genes Chromosomes Cancer
|
2005
|
0.85
|
|
22
|
Inherited variation in the PARP1 gene and survival from melanoma.
|
Int J Cancer
|
2014
|
0.85
|
|
23
|
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions.
|
Int J Cancer
|
2014
|
0.84
|
|
24
|
An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study.
|
Pigment Cell Melanoma Res
|
2013
|
0.84
|
|
25
|
The clinicopathological and gene expression patterns associated with ulceration of primary melanoma.
|
Pigment Cell Melanoma Res
|
2014
|
0.83
|
|
26
|
No Evidence for BRAF as a melanoma/nevus susceptibility gene.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.78
|
|
27
|
Clinicopathologic features of V600E and V600K melanoma--letter.
|
Clin Cancer Res
|
2012
|
0.78
|
|
28
|
Evaluation of PAX3 genetic variants and nevus number.
|
Pigment Cell Melanoma Res
|
2013
|
0.77
|